
|Articles|October 7, 2010
Highlights of dry eye Phase 2 clinical study revealed
ISTA Pharmaceuticals has highlighted results from its Phase 2 clinical study on Remura dry eye solution.
Advertisement
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement















































